You are currently viewing a new version of our website. To view the old version click .

Natural Bioactive Compounds from Fungi with Potential Antimicrobial Properties: New and Future Developments in Microbial Biotechnology

Special Issue Information

Dear Colleagues,

Fungi produce a wide range of natural products, often called secondary metabolites (low-molecular weight compounds), e.g., polyketides, non-ribosomal peptides, and terpenes. Interest in these compounds is considerable, as many natural products are of medical, industrial, and/or agricultural importance. 

In this Special Issue dedicated to “Natural Bioactive Compounds from Fungi with Potential Medicinal Properties: New and Future Developments in Microbial Biotechnology”, research papers and reviews on the search for new fungal metabolites for the pharmaceutical and agrochemical industries are welcome, providing new evidence about fungi as potential sources of bioactive or more largely useful properties.

Due to the increasing resistance of microorganisms to synthetic antibiotics, research on new antibacterial and new antifungal agents, as well as investigations of the biosynthetic pathways of already known or new molecules, at a laboratory scale or at a pilot level, could be emphasized.

Additional biotechnological processes for industrial applications and/or alternative use of fungal compounds in food, beverage, supplements, cosmetic, bio-based materials, or painting industries could also be part of this Special Issue.

Dr. Paola Angelini
Dr. Carolina Girometta
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobials
  • biological properties
  • biosynthesis
  • endophytic fungi
  • filamentous fungi
  • food, beverages, and supplements
  • fungal biotechnology
  • industrial application
  • secondary metabolites
  • screening

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382